抗発作薬 と 骨 の 健康
Paula V Gaete1, Valentina Cuellar-Rodríguez2, Carlos O Mendivil3,4
1Department of Neurology, Faculty of Medicine, Universidad Nacional de Colombia, Bogotá, Colombia.
Neurology and therapy
|September 1, 2025
まとめ
抗発作薬 (ASM) は,ビタミンDと骨細胞機能に影響を与えることで,骨の健康に悪影響を及ぼします. 骨への影響が少ないASMを優先し,骨折リスクを評価することは,患者にとって極めて重要です.
科学分野:
- 骨生物学と薬理学
- の 治療 と 患者 の 結果
背景:
- の治療にはしばしば抗発作薬 (ASM) が含まれており,寿命が長くなり,長期にわたって使用されます.
- 骨の健康に対するASMの悪影響に関する懸念が高まっています
研究 の 目的:
- 骨の生物学に対する様々な抗発作薬の影響に関する現在の知識をレビューし,統合する.
- 骨の健康に潜在的に低いリスクを持つASMを特定し,臨床実践に情報を提供するためです.
主な方法:
- 抗発作薬とその骨代謝への影響に関する既存の研究の文献レビュー.
- 異なるASMクラスがビタミンD,副甲状腺ホルモン (PTH),骨細胞 (骨質芽細胞および骨質芽細胞) に影響するメカニズムの分析.
主要な成果:
- サイトクロームP450誘導のASMは活性ビタミンDを低下させ,PTHを上昇させ,骨の再吸収を増加させます.
- バルプロ酸はビタミンDに影響を与え,骨格細胞を活性化し,骨格細胞を損なう.
- トピラマートは骨のミネラル密度が低下し,PTHが増加する;レベチラセタムは好ましい骨のプロファイルを示し,ラコサミドとラモトリジンは他のナトリウムチャネルブロッカーよりも好ましい.
結論:
- ASMはビタミンDとPTHの調節や骨細胞への直接的な効果を含む様々なメカニズムを通じて骨の生物学に大きな影響を及ぼします.
- 骨の健康に少ないASM,例えばレベチラセタム,ラコサミド,ラモトリジンは,臨床的に実行可能である場合に優先的に推奨されます.
- 骨折リスクの評価は,高リスクASMのエピレプシー患者にとって不可欠です.
関連する概念動画
01:17Antiepileptic Drugs: Calcium Channel Blockers
608
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
608
01:08Antiepileptic Drugs: Sodium Channel Blockers
869
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
869
01:20Antiepileptic Drugs: Potassium Channel Activators
274
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
274
01:14Antiepileptic Drugs: Glutamate Antagonists
511
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
511
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
445
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
445
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
635
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
635